LIGAND PHARMACEUTICALS INC's ticker is LGND and the CUSIP is 53220K504. A total of 207 filers reported holding LIGAND PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 0.55 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $11,684,850 | -3.7% | 195,007 | +15.9% | 0.00% | 0.0% |
| Q2 2023 | $12,132,014 | +6.3% | 168,266 | +8.5% | 0.00% | 0.0% |
| Q1 2023 | $11,407,647 | -7.5% | 155,079 | -16.0% | 0.00% | 0.0% |
| Q4 2022 | $12,329,277 | +18.8% | 184,570 | +53.2% | 0.00% | 0.0% |
| Q3 2022 | $10,374,000 | -21.5% | 120,464 | -18.7% | 0.00% | -50.0% |
| Q2 2022 | $13,223,000 | -17.6% | 148,211 | +4.0% | 0.00% | 0.0% |
| Q1 2022 | $16,038,000 | +33.2% | 142,568 | +82.9% | 0.00% | +100.0% |
| Q4 2021 | $12,037,000 | -9.6% | 77,933 | -18.4% | 0.00% | -50.0% |
| Q3 2021 | $13,314,000 | +13.7% | 95,562 | +7.1% | 0.00% | 0.0% |
| Q2 2021 | $11,709,000 | +17.8% | 89,261 | +36.9% | 0.00% | +100.0% |
| Q1 2021 | $9,938,000 | +115.0% | 65,187 | +40.3% | 0.00% | 0.0% |
| Q4 2020 | $4,622,000 | -52.1% | 46,474 | -54.1% | 0.00% | -50.0% |
| Q3 2020 | $9,659,000 | +63.4% | 101,317 | +91.7% | 0.00% | +100.0% |
| Q2 2020 | $5,912,000 | +331.2% | 52,851 | +180.5% | 0.00% | – |
| Q1 2020 | $1,371,000 | -89.1% | 18,844 | -84.4% | 0.00% | -100.0% |
| Q4 2019 | $12,558,000 | +217.4% | 120,416 | +203.0% | 0.00% | +200.0% |
| Q3 2019 | $3,956,000 | +4.9% | 39,747 | +20.3% | 0.00% | 0.0% |
| Q2 2019 | $3,772,000 | +178.0% | 33,049 | +206.5% | 0.00% | – |
| Q1 2019 | $1,357,000 | -92.0% | 10,784 | -91.4% | 0.00% | -100.0% |
| Q4 2018 | $17,023,000 | -48.7% | 125,445 | +3.8% | 0.01% | -37.5% |
| Q3 2018 | $33,183,000 | +20.7% | 120,891 | -8.9% | 0.01% | +14.3% |
| Q2 2018 | $27,485,000 | +97.6% | 132,669 | +57.5% | 0.01% | +75.0% |
| Q1 2018 | $13,909,000 | -13.9% | 84,218 | -28.6% | 0.00% | 0.0% |
| Q4 2017 | $16,160,000 | +19.3% | 118,016 | +18.6% | 0.00% | 0.0% |
| Q3 2017 | $13,542,000 | +271.2% | 99,466 | +231.0% | 0.00% | +300.0% |
| Q2 2017 | $3,648,000 | -52.6% | 30,049 | -58.7% | 0.00% | 0.0% |
| Q1 2017 | $7,698,000 | -55.3% | 72,720 | -57.1% | 0.00% | -66.7% |
| Q4 2016 | $17,238,000 | +341.7% | 169,646 | +343.6% | 0.00% | +200.0% |
| Q3 2016 | $3,903,000 | -74.9% | 38,244 | -70.7% | 0.00% | -83.3% |
| Q2 2016 | $15,542,000 | +12.3% | 130,313 | +0.8% | 0.01% | +20.0% |
| Q1 2016 | $13,840,000 | +49.7% | 129,242 | +51.6% | 0.01% | +66.7% |
| Q4 2015 | $9,243,000 | +515.8% | 85,245 | +386.3% | 0.00% | +200.0% |
| Q3 2015 | $1,501,000 | -79.8% | 17,528 | -76.3% | 0.00% | -66.7% |
| Q2 2015 | $7,449,000 | +1082.4% | 73,831 | +804.2% | 0.00% | – |
| Q1 2015 | $630,000 | +4.8% | 8,165 | -27.8% | 0.00% | – |
| Q4 2014 | $601,000 | -21.6% | 11,302 | -30.8% | 0.00% | – |
| Q3 2014 | $767,000 | -42.0% | 16,335 | -23.1% | 0.00% | -100.0% |
| Q2 2014 | $1,322,000 | -42.5% | 21,235 | -37.9% | 0.00% | 0.0% |
| Q1 2014 | $2,300,000 | -17.4% | 34,179 | -35.4% | 0.00% | 0.0% |
| Q4 2013 | $2,783,000 | +56.3% | 52,925 | +28.8% | 0.00% | 0.0% |
| Q3 2013 | $1,780,000 | -8.1% | 41,104 | -20.6% | 0.00% | 0.0% |
| Q2 2013 | $1,936,000 | – | 51,752 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Knott David M Jr | 115,000 | $7,682 | 2.90% |
| VILLERE ST DENIS J & CO LLC | 483,347 | $32,287 | 2.52% |
| Monarch Partners Asset Management LLC | 62,327 | $4,163,444 | 1.23% |
| Chicago Capital, LLC | 319,054 | $21,312,820 | 1.18% |
| RICE HALL JAMES & ASSOCIATES, LLC | 285,634 | $19,080,351 | 1.09% |
| Stephens Investment Management Group LLC | 454,416 | $30,713,977 | 0.56% |
| Smith, Graham & Co., Investment Advisors, LP | 65,372 | $4,366,850 | 0.53% |
| WOODSTOCK CORP | 55,014 | $3,674,935 | 0.49% |
| Court Place Advisors, LLC | 15,533 | $1,037,605 | 0.38% |
| ISTHMUS PARTNERS, LLC | 19,830 | $1,324,644 | 0.20% |